The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with gene mutation testing in United States veterans with metastatic castration-resistant prostate cancer.
 
Anna Hung
Research Funding - AstraZeneca (Inst)
 
Yanhong Li
No Relationships to Disclose
 
Danielle Candelieri
No Relationships to Disclose
 
Patrick Alba
No Relationships to Disclose
 
Tori Anglin-Foote
No Relationships to Disclose
 
Kyung Min Lee
No Relationships to Disclose
 
Fatai Agiri
No Relationships to Disclose
 
Cristina Perez
No Relationships to Disclose
 
Weiyan Li
Employment - AstraZeneca; AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Suvina Amin
Employment - AstraZeneca
 
Shan Jiang
Employment - Merck
 
Scott L. DuVall
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Innocrin Pharma (Inst); Janssen (Inst); Kantar Health (Inst); Lilly (Inst); Myriad Genetics (Inst); Novartis (Inst); Parexel International Corporation (Inst)
 
Yu-Ning Wong
No Relationships to Disclose
 
Shelby D. Reed
Stock and Other Ownership Interests - Medtronic (I)
Consulting or Advisory Role - AstraZeneca; Ipsen; PhRMA Foundation; SVC Systems
Research Funding - Abbott Vascular (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); Janssen Research & Development (Inst); Medical Device Innovation Consortium (Inst); Monteris Medical (Inst)
 
Julie Ann Lynch
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); CardioDx (Inst); Genomic Health (Inst); Janssen (Inst); Myriad Genetics (Inst)